Beef for Prediabetes

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
PrediabetesBeef - Other
Eligibility
18 - 74
All Sexes
What conditions do you have?
Select

Study Summary

The objective of this study is to assess and compare the effects of usual diets containing lean beef vs. lean poultry on pancreatic beta-cell responses in men and women with prediabetes.

Eligible Conditions
  • Prediabetes

Treatment Effectiveness

Effectiveness Progress

1 of 3

Study Objectives

1 Primary · 13 Secondary · Reporting Duration: 4 weeks

4 weeks
Fasting C-peptide
Fibrinogen
Glucagon
Glucagon-like petide-1 (GLP-1)
Glucose-dependent inhibitory polypeptide (GIP)
High-sensitivity C-reactive protein
Homeostasis model assessments of insulin sensitivity (HOMA2%S)
Homeostasis model assessments of pancreatic beta-cell function (HOMA2%B)
Insulin
Insulin sensitivity
Interleukin-6
Mixed meal tolerance test (MTT) Disposition index
Ratio of incremental area under the curve (iAUC) for C-peptide to iAUC for glucose
Tumor necrosis factor alpha

Trial Safety

Safety Progress

1 of 3

Trial Design

2 Treatment Groups

Poultry
1 of 2
Beef
1 of 2

Active Control

Experimental Treatment

28 Total Participants · 2 Treatment Groups

Primary Treatment: Beef · No Placebo Group · N/A

Beef
Other
Experimental Group · 1 Intervention: Beef · Intervention Types: Other
Poultry
Other
ActiveComparator Group · 1 Intervention: Poultry · Intervention Types: Other

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: 4 weeks

Who is running the clinical trial?

National Cattlemen's Beef AssociationOTHER
22 Previous Clinical Trials
1,048 Total Patients Enrolled
Midwest Center for Metabolic and Cardiovascular ResearchLead Sponsor
18 Previous Clinical Trials
737 Total Patients Enrolled
Kevin Maki, PhDStudy DirectorMB Clinical Research & Consulting, LLC
10 Previous Clinical Trials
951 Total Patients Enrolled

Eligibility Criteria

Age 18 - 74 · All Participants · 10 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
You have a BMI of 25.0-39.9 kg/m2, inclusive.
You have a score of 7-10 on the Vein Access Scale.
You are normally active and judged by the Investigator to be in general good health on the basis of medical history and screening measurements.
You are willing to consume study-related foods and follow the dietary instructions during each 4-week treatment period.
You are willing to come to the clinic for study food pick-up if needed.
You are willing to follow your usual physical activity pattern throughout the study period.
You are not planning to change your smoking habits during the study period.